Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Arcturus Therapeutics Holdings (ARCT) Return on Invested Capital: 2023-2025

  • Arcturus Therapeutics Holdings' Return on Invested Capital was N/A to -0.31% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.31%, marking a year-over-year change of. This contributed to the annual value of -0.37% for FY2024, which is N/A change from last year.
  • Arcturus Therapeutics Holdings' Return on Invested Capital amounted to -0.31% in Q2 2025, which was up 18.48% from -0.38% recorded in Q4 2024.
  • In the past 5 years, Arcturus Therapeutics Holdings' Return on Invested Capital ranged from a high of 0.21% in Q3 2023 and a low of -0.38% during Q4 2024.
  • For the 3-year period, Arcturus Therapeutics Holdings' Return on Invested Capital averaged around -0.16%, with its median value being -0.31% (2025).